Net Cash Provided by (Used in) Financing Activities of BIOLASE, INC from 31 Dec 2010 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BIOLASE, INC quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Mar 2024.
  • BIOLASE, INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $5,647,000, a 34% decline year-over-year.
  • BIOLASE, INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $17,434,000, a 279% increase from 2022.
  • BIOLASE, INC annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4,603,000, a 85% decline from 2021.
  • BIOLASE, INC annual Net Cash Provided by (Used in) Financing Activities for 2021 was $29,954,000, a 23% increase from 2020.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

BIOLASE, INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $5,647,000 -$2,870,000 -34% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q1 2023 $8,517,000 +$8,517,000 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2022 $0 -$29,825,000 -100% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $29,825,000 +$29,942,000 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $117,000 -$120,000 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q1 2019 $3,000* -$1,621,000 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $1,624,000 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q1 2013 $1,700,000 +$1,423,000 +514% 01 Jan 2013 31 Mar 2013 10-Q 10 May 2013 2013 Q1
Q1 2012 $277,000 -$4,666,000 -94% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q1 2011 $4,943,000 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012 2012 Q1

BIOLASE, INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $17,434,000 +$12,831,000 +279% 01 Jan 2023 31 Dec 2023 10-K 21 Mar 2024 2023 FY
2022 $4,603,000 -$25,351,000 -85% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $29,954,000 +$5,605,000 +23% 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2024 2023 FY
2020 $24,349,000 +$13,628,000 +127% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2023 2022 FY
2019 $10,721,000 -$514,000 -4.6% 01 Jan 2019 31 Dec 2019 10-K 17 Mar 2022 2021 FY
2018 $11,235,000 -$10,383,000 -48% 01 Jan 2018 31 Dec 2018 10-K 31 Mar 2021 2020 FY
2017 $21,618,000 +$12,268,000 +131% 01 Jan 2017 31 Dec 2017 10-K 30 Mar 2020 2019 FY
2016 $9,350,000 01 Jan 2016 31 Dec 2016 10-K 08 Mar 2019 2018 FY
2013 $8,847,000 +$7,288,000 +467% 01 Jan 2013 31 Dec 2013 10-K 17 Mar 2014 2013 FY
2012 $1,559,000 -$13,828,000 -90% 01 Jan 2012 31 Dec 2012 10-K 17 Mar 2014 2013 FY
2011 $15,387,000 +$12,573,000 +447% 01 Jan 2011 31 Dec 2011 10-K 17 Mar 2014 2013 FY
2010 $2,814,000 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.